68 related articles for article (PubMed ID: 6977358)
1. Anti-neuraminidase antibodies: which substrate should be used to test their effect on influenza virus neuraminidase.
Mountford CE; Holmes KT; Hampson AW
Biochem Biophys Res Commun; 1981 Nov; 103(2):469-74. PubMed ID: 6977358
[No Abstract] [Full Text] [Related]
2. Effect of monoclonal anti-neuraminidase antibodies on the kinetic behavior of influenza virus neuraminidase.
Mountford CE; Grossman G; Holmes KT; O'Sullivan WJ; Hampson AW; Raison RL; Webster R
Mol Immunol; 1982 Jun; 19(6):811-6. PubMed ID: 7110144
[TBL] [Abstract][Full Text] [Related]
3. Crystalline monoclonal fab fragment with specificity towards an influenza virus neuraminidase.
Colman PM; Gough KH; Lilley GG; Blagrove RJ; Webster RG; Laver WG
J Mol Biol; 1981 Nov; 152(3):609-14. PubMed ID: 7328664
[No Abstract] [Full Text] [Related]
4. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase subtype or neuraminidase antibody specificity.
Pedersen JC
Methods Mol Biol; 2008; 436():67-75. PubMed ID: 18370042
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus neuraminidase alters allogeneic T cell proliferation.
Oh S; Eichelberger MC
Virology; 1999 Nov; 264(2):427-35. PubMed ID: 10562504
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
Kortt AA; Nice E; Gruen LC
Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
[TBL] [Abstract][Full Text] [Related]
7. Enzymological characteristics of avian influenza A virus neuraminidase.
Kiyotani K; Takei N; Senoo M; Takao S; Otsuki K; Tsubokura M; Yoshida T
Microbiol Immunol; 1987; 31(11):1131-5. PubMed ID: 2451112
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase-inhibition assay for the identification of influenza A virus neuraminidase virus subtype or neuraminidase antibody specificity.
Pedersen JC
Methods Mol Biol; 2014; 1161():27-36. PubMed ID: 24899417
[TBL] [Abstract][Full Text] [Related]
9. Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.
Deshairs C; Kessler N; Aymard M; Quash GA
J Gen Virol; 1986 Mar; 67 ( Pt 3)():409-18. PubMed ID: 3950578
[TBL] [Abstract][Full Text] [Related]
10. Cooperative neuraminidase activity in a paramyxovirus.
Mahon PJ; Deng R; Mirza AM; Iorio RM
Virology; 1995 Oct; 213(1):241-4. PubMed ID: 7483268
[TBL] [Abstract][Full Text] [Related]
11. The equilibrium constant for the interaction between a monoclonal Fab fragment and an influenza virus neuraminidase.
Jackson DC; Howlett GJ; Nestorowicz A; Webster RG
J Immunol; 1983 Mar; 130(3):1313-6. PubMed ID: 6822736
[TBL] [Abstract][Full Text] [Related]
12. Viral neuraminidase and cellular ectosialyltransferase in human lymphoblastoid cells infected with influenza virus.
Duc Dodon M; Cecchelli R; Cacan R; Gazzolo L; Verbert A
Biochimie; 1984 Jun; 66(6):493-6. PubMed ID: 6498232
[TBL] [Abstract][Full Text] [Related]
13. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
14. Characterization of sialidase from an influenza A (H3N2) virus strain: kinetic parameters and substrate specificity.
França de Barros J; Sales Alviano D; da Silva MH; Dutra Wigg M; Sales Alviano C; Schauer R; dos Santos Silva Couceiro JN
Intervirology; 2003; 46(4):199-206. PubMed ID: 12931027
[TBL] [Abstract][Full Text] [Related]
15. Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.
Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Xu KW; Lorbetskie B; Gingras G; Aubin Y; Van Domselaar G; Girard M; He R; Li X
Vaccine; 2010 Aug; 28(36):5774-84. PubMed ID: 20621113
[TBL] [Abstract][Full Text] [Related]
16. Difficulties in standardizing the neuraminidase content of influenza vaccines.
Gérentes L; Kessler N; Aymard M
Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
[TBL] [Abstract][Full Text] [Related]
17. [Determination of the neuraminidase specificity of influenza A and B viruses using a modified lectin test].
Liubovtseva OV; Zakstel'skaia LIa; Ivanova VT; Oskerko TA
Vopr Virusol; 1983; 28(6):663-8. PubMed ID: 6199899
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
[TBL] [Abstract][Full Text] [Related]
19. [Enzymologically different characteristics between influenza A and B virus neuraminidases].
Takei N; Kiyotani K; Senoo M; Matsuo Y
Uirusu; 1986 Jun; 36(1):119-23. PubMed ID: 3776104
[No Abstract] [Full Text] [Related]
20. Steps in maturation of influenza A virus neuraminidase.
Saito T; Taylor G; Webster RG
J Virol; 1995 Aug; 69(8):5011-7. PubMed ID: 7541844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
